Representation the science deserves
We represent distinguished scientists whose patented or near-patented molecules sit at the frontier of medicine. You stay on the science; we handle the room you are not in.
The moment
Between 2025 and 2030, a wave of patent expirations is pulling billions in annual revenue out of large pharma. That gap is filled by outside molecules, and the inventors who arrive prepared, with an airtight patent estate and disciplined representation, are the ones who capture the value.
What we do
Exclusive representation
We work directly and exclusively with the scientist, protecting their interests and freeing them to stay focused on the research.
Targeted outreach
We identify and approach the specific companies whose pipelines and stage make them real candidates, not blast lists.
A competitive process
We run qualified partners in parallel to preserve tension, so the asset is valued on its merits, not the first offer.
Deal structuring
Term sheets, milestones, royalties, and co-development economics, negotiated to the agreement the science deserves.
Rare disease & oncology
Depth where breakthrough science means the most, and where conventional pipelines have fallen short.
Confidentiality
Every disclosure and every term sheet held in strict confidence, protected at every step.
Where we are
Modulus currently represents The Healthy Aging Company as its exclusive worldwide partnering and licensing representative for ALF5755, a first-in-class REG3A (HIP/PAP) therapeutic delivered through a proprietary AAV gene-therapy platform, championed by Prof. Christian Bréchot.